表紙
市場調査レポート

競合分析:癌ワクチン

Competitor Analysis: Cancer Vaccines

発行 La Merie Publishing 商品コード 221876
出版日 ページ情報 英文 179 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.39円で換算しております。
Back to Top
競合分析:癌ワクチン Competitor Analysis: Cancer Vaccines
出版日: 2014年03月24日 ページ情報: 英文 179 Pages
概要

2013年現在、140種類もの癌ワクチンが治験過程にありますが、そのうち3製品が認証・上市され、合計で23億8500万米ドルもの売上高を達成しています。治験中のワクチンのうち、ペプチドワクチン・タンパク質ワクチンが43%を占め、ついで樹枝状細胞ワクチンと腫瘍細胞(株)ワクチンが15%づつ、DNA/RNAワクチンが17%を占めています。

当レポートでは、癌の予防および治療用ワクチンについて調査し、現在進行中の研究開発(R&D)プロジェクトの概要(抗原成分別の内訳)や、競合企業別の動向およびパイプライン情報(薬剤コード、標的/機能メカニズム、企業概略、製品カテゴリー、適応症、進捗状況ほか)などをまとめ、概略以下の構成でお届けします。

第1章 癌ワクチン:主要成分別の内訳

  • ペプチドワクチン
  • タンパク質ワクチン
  • イディオタイプ抗体ワクチン
  • DNAワクチン(ネイキッド/ウイルスベクターつき)
  • RNAワクチン
  • ウイルス様粒子(VLP)ワクチン
  • 樹枝状細胞ワクチン
  • 腫瘍細胞または腫瘍細胞株ワクチン
  • 微生物ワクチン
  • その他の/未定義のワクチン

第2章 企業別癌ワクチン研究開発パイプライン(計100社分)

  • ABIVAX
  • Activartis
  • Aduro BioTech
  • Advanced Cancer Therapeutics
  • Advaxis
  • Aeterna Zentaris
  • Agenus
  • Antigen Express
  • ApoVax
  • Ascend Biopharmaceuticals
  • Asterias Biotherapeutics
  • Avax Technologies
  • Bavarian Nordic
  • Bellicum Pharmaceuticals
  • Bharat Biotech
  • Biocon
  • BioLife Science
  • BioNTech
  • Biontech RNA Pharmaceuticals
  • Biovest International
  • Celgene
  • Celldex Therapeutics
  • Cellular Biomedicine
  • CSL
  • CureVac
  • 大日本住友製薬
  • DCPrime
  • Delta-Vir
  • Dendreon
  • Etubics
  • Galena Biopharma
  • Genexine
  • Genticel
  • GlaxoSmithKline
  • Gliknik
  • GlobeImmune
  • Gradalis
  • H. Lee Moffitt Cancer Center and Research Institute
  • Heat Biologics
  • Icon Genetics
  • Immatics biotechnologies
  • Immune Design
  • Immunicum
  • ImmunoCellular Therapeutics
  • ImmunoFrontier
  • Immunovaccine
  • Immunovative Therapies
  • Immutep
  • Innate Immunotherapeutics
  • Inovio Pharmaceuticals
  • ISA Pharmaceuticals
  • KAEL-GemVax
  • MabVax
  • Mayo Clinic
  • MediGene
  • Mediolanum
  • Merck
  • Merck Serono
  • Mologen
  • 桃太郎源
  • NewLink Genetics
  • Northwest Biotherapeutics
  • Novartis
  • NovaRx
  • Ohio State University Comprehensive Cancer Center
  • Oncopep
  • OncoTherapy Science
  • Oncothyreon
  • Oncovir
  • 小野薬品工業
  • Oryx
  • 大塚製薬
  • Oxford BioMedica
  • PDS Biotechnology
  • Polynoma
  • Prima Biomed
  • Profectus BioSciences
  • Roche
  • Scancell
  • Shanghai Zerun Biotech Co
  • Shenyang Sunshine Pharmaceutical Co (3SBio)
  • 滋賀医科大学
  • 塩野義製薬
  • Sidney Kimmel Comprehensive Cancer Center
  • Stemline Therapeutics
  • TapImmune
  • Targovax
  • Transgene
  • Ultimovacs
  • University Hospital Grenoble
  • University of Arkansas
  • Vaccibody
  • Vaccinex
  • Vaccinogen
  • Vaxart
  • Vaxil Biotherapeutics
  • VAXIMM
  • Vaxon Biotech
  • ViroMed
  • Xiamen Innovax Biotech
  • Zensun Sci & Tech Co

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: LMCA0118

The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines to fight cancer as of March 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

Projects are listed according to their main antigenic constituents: peptides, recombinant proteins, idiotype antibody, DNA (plasmid, expression vector), RNA, virus-like particles (VLP), dendritic cells, tumor cells (tumor cell lines), microorganism-based and others.

Of the 140 clinical stage cancer vaccines, three were approved and are commercialized in the major pharmaceutical markets with combined 2013 sales of US$ 2,385 mln. Peptides and proteins make out 43% of clinical stage cancer vaccines, followed by dendritic cell and tumor cell (line)-based cancer vaccines with each contributing 15% to the clinical cancer vaccine pipeline. DNA- and RNA-based cancer vaccines maked out 17% of the clinical portfolio.

The report includes a compilation of currently active projects in research and development for prophylaxis and therapy of cancer. In addition, the report lists company-specific R&D pipelines of cancer vaccines.

Competitor projects are listed in a tabular format providing information on:

  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.

Table of Contents

1. Cancer Vaccines by Main Composition

  • Peptide-based Cancer Vaccines
  • Protein-based Cancer Vaccines
  • Idiotype Antibody-based Cancer Vaccines
  • DNA-based Cancer Vaccines: naked and virally vectored
  • RNA-based Cancer Vaccines
  • Virus-Like Particle (VLP)-based Cancer Vaccines
  • Dendritic Cell-based Cancer Vaccines
  • Tumor Cell and Tumor Cell Line - based Cancer Vaccines
  • Microorganism-based Cancer Vaccines
  • Other and Not Defined Cancer Vaccines

2. Corporate Cancer Vaccines R&D Pipelines

  • ABIVAX
  • Activartis
  • Aduro BioTech
  • Advanced Cancer Therapeutics
  • Advaxis
  • Aeterna Zentaris
  • Agenus
  • Antigen Express
  • ApoVax
  • Ascend Biopharmaceuticals
  • Asterias Biotherapeutics
  • Avax Technologies
  • Bavarian Nordic
  • Bellicum Pharmaceuticals
  • Bharat Biotech
  • Biocon
  • BioLife Science
  • BioNTech
  • Biontech RNA Pharmaceuticals
  • Biovest International
  • Celgene
  • Celldex Therapeutics
  • Cellular Biomedicine
  • CSL
  • CureVac
  • Dainippon Sumitomo Pharma
  • DCPrime
  • Delta-Vir
  • Dendreon
  • Etubics
  • Galena Biopharma
  • Genexine
  • Genticel
  • GlaxoSmithKline
  • Gliknik
  • GlobeImmune
  • Gradalis
  • H. Lee Moffitt Cancer Center and Research Institute
  • Heat Biologics
  • Icon Genetics
  • Immatics biotechnologies
  • Immune Design
  • Immunicum
  • ImmunoCellular Therapeutics
  • ImmunoFrontier
  • Immunovaccine
  • Immunovative Therapies
  • Immutep
  • Innate Immunotherapeutics
  • Inovio Pharmaceuticals
  • ISA Pharmaceuticals
  • KAEL-GemVax
  • MabVax
  • Mayo Clinic
  • MediGene
  • Mediolanum
  • Merck
  • Merck Serono
  • Mologen
  • Momotaro-Gene
  • NewLink Genetics
  • Northwest Biotherapeutics
  • Novartis
  • NovaRx
  • Ohio State University Comprehensive Cancer Center
  • Oncopep
  • OncoTherapy Science
  • Oncothyreon
  • Oncovir
  • Ono Pharmaceutical
  • Oryx
  • Otsuka Pharmaceutical
  • Oxford BioMedica
  • PDS Biotechnology
  • Polynoma
  • Prima Biomed
  • Profectus BioSciences
  • Roche
  • Scancell
  • Shanghai Zerun Biotech Co
  • Shenyang Sunshine Pharmaceutical Co (3SBio)
  • Shiga University
  • Shionogi
  • Sidney Kimmel Comprehensive Cancer Center
  • Stemline Therapeutics
  • TapImmune
  • Targovax
  • Transgene
  • Ultimovacs
  • University Hospital Grenoble
  • University of Arkansas
  • Vaccibody
  • Vaccinex
  • Vaccinogen
  • Vaxart
  • Vaxil Biotherapeutics
  • VAXIMM
  • Vaxon Biotech
  • ViroMed
  • Xiamen Innovax Biotech
  • Zensun Sci & Tech Co
Back to Top